https://www.selleckchem.com/pr....oducts/empagliflozin
Comparative data on glucose disorders using fasting blood samples between people living with HIV (PLWH) and the general population are lacking. The objective of this study was to compare the prevalence and risk factors of obesity and disturbances in glucose homeostasis between PLWH treated with modern antiretroviral therapy and the general population. Adjusted prevalence of obesity, features of insulin resistance (triglyceridehigh-density lipoprotein cholesterol ratio and alanine aminotransferase), impaired fasting glucose
Like
Comment
Share
